News & Updates
Filter by Specialty:
Show Multimedia Only
Atezolizumab plus chemo, bevacizumab improves survival in R/M cervical cancer
02 Sep 2025
byStephen Padilla
The addition of atezolizumab to first-line chemotherapy plus bevacizumab delivers significant improvements in survival among patients with PD-L1+ or PD-L1‒ persistent, recurrent, or metastatic (R/M) cervical cancer, results of a post hoc analysis of the BEATcc study have shown.
Atezolizumab plus chemo, bevacizumab improves survival in R/M cervical cancer
02 Sep 2025
HK data: Clozapine may increase infection risk in schizophrenia
02 Sep 2025
byKanas Chan
Clozapine is associated with a moderately increased risk of infection vs olanzapine in patients with schizophrenia in Hong Kong, with the association being notably stronger in older age groups, according to researchers from the Department of Family Medicine and Primary Care at the University of Hong Kong (HKU).
